- Home
- TERN vs OFIX Comparison
TERN vs OFIX Comparison
Compare TERN & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TERN
- OFIX
- Stock Information
- Founded
- TERN 2017
- OFIX 1987
- Country
- TERN United States
- OFIX United States
- Employees
- TERN N/A
- OFIX N/A
- Industry
- TERN Biotechnology: Pharmaceutical Preparations
- OFIX Medical/Dental Instruments
- Sector
- TERN Health Care
- OFIX Health Care
- Exchange
- TERN Nasdaq
- OFIX Nasdaq
- Market Cap
- TERN 634.5M
- OFIX 562.0M
- IPO Year
- TERN 2021
- OFIX N/A
- Fundamental
- Price
- TERN $7.22
- OFIX $14.55
- Analyst Decision
- TERN Buy
- OFIX Strong Buy
- Analyst Count
- TERN 6
- OFIX 5
- Target Price
- TERN $13.99
- OFIX $21.50
- AVG Volume (30 Days)
- TERN 1.2M
- OFIX 489.1K
- Earning Date
- TERN 08-05-2025
- OFIX 11-06-2025
- Dividend Yield
- TERN N/A
- OFIX N/A
- EPS Growth
- TERN N/A
- OFIX N/A
- EPS
- TERN N/A
- OFIX N/A
- Revenue
- TERN N/A
- OFIX $809,030,000.00
- Revenue This Year
- TERN N/A
- OFIX $3.86
- Revenue Next Year
- TERN N/A
- OFIX $5.57
- P/E Ratio
- TERN N/A
- OFIX N/A
- Revenue Growth
- TERN N/A
- OFIX 4.84
- 52 Week Low
- TERN $1.87
- OFIX $10.24
- 52 Week High
- TERN $11.40
- OFIX $20.73
- Technical
- Relative Strength Index (RSI)
- TERN 59.36
- OFIX 66.28
- Support Level
- TERN $6.78
- OFIX $14.47
- Resistance Level
- TERN $7.78
- OFIX $15.03
- Average True Range (ATR)
- TERN 0.49
- OFIX 0.40
- MACD
- TERN -0.02
- OFIX -0.09
- Stochastic Oscillator
- TERN 63.82
- OFIX 44.90
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
About OFIX Orthofix Medical Inc. (DE)
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.